Earnings Preview: Colgate-Palmolive - Analyst Blog
July 26 2011 - 11:15AM
Zacks
Colgate-Palmolive Co.(CL) is scheduled to
release its second-quarter 2011 results on Thursday, July 28, 2011.
The Zacks Consensus Estimate for the quarter is pegged at $1.26 a
share, representing a year-over-year estimated growth of 8.6%.
1Q11 Performance Recap
Colgate-Palmolive Company posted first quarter of fiscal 2011
earnings of $1.16 per share, at par with the Zacks Consensus
Estimate. However, earnings fell short of the prior-year figure of
$1.21 per share.
Global net sales increased 4.5% year over year to $3,994 million
primarily due to a 3% benefit from foreign exchange and a 2%
addition from global unit volume, which was offset by a 0.5% fall
in pricing. On an organic basis (excluding foreign exchange,
acquisitions and divestitures), sales increased 1.5% in the
quarter. Global net sales beat the Zacks Consensus Revenue Estimate
of $3,956 million.
Agreement of Analysts
Over the past 30 days, 4 of the 20 analysts covering Colgate for
the second quarter of fiscal 2011 have revised their earnings
estimates upward with one stray movement in the opposite direction.
In the last 7 days, 2 analysts have increased their estimates with
no movement in the negative direction.
For fiscal 2011, 4 of the 23 analysts following the stock have
revised their estimates upward over the last 30 days with 1 analyst
moving in the opposite direction. In the last 7 days, 2 analysts
have increased their estimates with no movement in the negative
direction.
Magnitude of Estimate Revisions
With little impact from earnings revisions by the analysts in
the last 7 and 30 days, the Zacks Consensus Estimate for the second
quarter of fiscal 2011 remained unchanged at $1.26 per share. For
fiscal 2011, the Consensus Estimate has inched up by 1 cent to
$5.08 in the last 30 days.
Surprise History
With respect to earnings surprises, Colgate showed a favorable
trend in the last four quarters. The company has recorded surprises
with a low of 0.0% and a high of 1.7%. On an average, the earnings
surprise was a positive 1.1%. Based on the current flow, we expect
the company to come up with healthy results in the upcoming
quarter.
Our Recommendation
Colgate-Palmolive is the industry leader in oral care and
commands market-leading positions in many personal care product
categories. Furthermore, a strong portfolio of globally recognized
brands, including Colgate, Palmolive, Mennen, Softsoap, Irish
Spring, Protex, Sorriso, Kolynos, Elmex, Ajax and Axion, provides a
competitive advantage to the company and strengthens its dominant
position in the market.
Moreover, in an effort to further drive growth, Colgate seeks to
capture significant opportunities by identifying and targeting
consumer needs within its core categories. The company further
focuses on innovation and the deployment of valuable consumer and
shopper insights for developing successful new products regionally,
which are then rolled out on a global basis.
Colgate-Palmolive, which competes with names like
Procter & Gamble Company (PG) and
Church & Dwight Company Inc. (CHD), maintains
a Zacks #2 Rank, translating into a short-term "Buy"
recommendation. Our long-term recommendation on the stock remains
"Neutral".
CHURCH & DWIGHT (CHD): Free Stock Analysis Report
COLGATE PALMOLI (CL): Free Stock Analysis Report
PROCTER & GAMBL (PG): Free Stock Analysis Report
Zacks Investment Research
Colgate Palmolive (NYSE:CL)
Historical Stock Chart
From May 2024 to Jun 2024
Colgate Palmolive (NYSE:CL)
Historical Stock Chart
From Jun 2023 to Jun 2024